Reporting owner · CIK 0001840006
Cohen Neil Harris
Visual SEC Form 4 history across 1 companies, 9 transactions and 1 filings.
DIRChemomab Therapeutics Ltd.
Open-market mix
0%buys
Open-market buy performance
90-day forward return on this insider's open-market purchases
Forward return is not available yet
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Buys Sells
Net value flow
Buys minus sells
Jul 20
$0
Apr 21
$0
Mar 22
$0
Mar 23
$0
Mar 24
$0
Mar 25
$0
Mar 26
$0
Aug 26
−$6.5K
Transaction texture
Ownership and ticket size
Average P/S size$3.3K
Median P/S size$3.3K
Direct9
Indirect0
Aug 28, 2026sale
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
Latest transaction
sale at Chemomab Therapeutics Ltd. on Aug 28, 2026 valued at $2,800.
Review SEC filingLatest buy
No open-market insider purchase is available.
Associated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| CMMB | Cohen Neil Harris | DIR | grant | 5.17k | $0 | A | — | 09/01 | 03/16 | |
| CMMB | Cohen Neil Harris | DIR | grant | 3.82k | $0 | A | — | 09/01 | 03/16/2025 | |
| CMMB | Cohen Neil Harris | DIR | grant | 2.52k | $0 | A | — | 09/01 | 03/18/2024 | |
| CMMB | Cohen Neil Harris | DIR | grant | 1.71k | $0 | A | — | 09/01 | 03/21/2023 | |
| CMMB | Cohen Neil Harris | DIR | grant | 1.70k | $0 | A | — | 09/01 | 03/07/2022 | |
| CMMB | Cohen Neil Harris | DIR | grant | 2.97k | $0 | A | — | 09/01 | 04/19/2021 | |
| CMMB | Cohen Neil Harris | DIR | grant | 172 | $0 | A | — | 09/01 | 07/16/2020 | |
| CMMB | Cohen Neil Harris | DIR | sale | 1.00k | -$280k | S | — | 09/01 | 08/28 | |
| CMMB | Cohen Neil Harris | DIR | sale | 1.30k | -$371k | S | — | 09/01 | 08/27 |
Cohen Neil Harris Insider Activity FAQ
SEC Form 4 context
Who is Cohen Neil Harris?
Cohen Neil Harris is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001840006.
Which companies has Cohen Neil Harris reported transactions for?
Chemomab Therapeutics Ltd.
When was Cohen Neil Harris's latest insider buy?
No open-market insider purchase is available for this period.
When was Cohen Neil Harris's latest insider sale?
sale at Chemomab Therapeutics Ltd. on Aug 28, 2026 valued at $2,800.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.